Search

everythinglearnresearchcommunity

for

Search:↓

The healthcare for transgender veterans could be better with a more unified team approach.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

The conclusion is that sex-verification in sports was harmful and changes have been made to address this.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Baldness challenged men's self-image and masculinity in Britain from the late 19th to early 20th centuries, leading to a market for hair loss treatments.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Gender affirmation surgery improves personal appearance and self-esteem.

Hair transplantation is important for transgender patients to enhance their masculine or feminine appearance.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

Male gender and family history predict alopecia areata recurrence.

Older male COVID-19 patients are more likely to experience hair loss.

Women are more likely than men to hide their age due to societal pressures.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.